Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone 100mg vs 200mg in Septic Shock
NCT02266264Phase 4Completed
- Sponsor
- Srinakharinwirot University
- Start
- Oct 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in septic shock, sponsored by Srinakharinwirot University. Started Oct 2014; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02266264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266264.